Administration of rosiglitazone led to normalization of these markers, although the observed decrease did not reach statistical significance.
← all excerpts
Repositioning of Anti-Diabetic Drugs against Dementia: Insight from Molecular Perspectives to Clinical Trials.
1
—
—